HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control CompletedThis study tested the safety and effectiveness of a two-drug combination (pembrolizumab/vibostolimab) in people with advanced blood cancers that had returned or stopped responding to other treatments. It involved 192 participants with various types of lymphoma or multiple myeloma…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Supercharged cord blood offers new hope for cancer patients
Disease control CompletedThis study tested whether a new, lab-expanded cord blood transplant (called NiCord) works better than a standard cord blood transplant for patients with blood cancers like leukemia and lymphoma. The goal was to see if the expanded cells help patients recover their immune systems …
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Two-Step transplant aims to boost survival in tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant method for patients with high-risk blood cancers like leukemia and lymphoma. It used a drug called cyclophosphamide before the transplant to help prevent a dangerous complication called graft-versus-host disease. The goal was to i…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New transplant strategy aims to save more lives by taming dangerous side effects
Disease control CompletedThis study tested if giving the drug cyclophosphamide *after* a stem cell transplant, instead of before, could make transplants safer and more effective for people with blood cancers. It focused on patients who needed a transplant but did not have a perfectly matched sibling dono…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New scan could spare patients from long, toxic treatments
Diagnosis CompletedThis study aimed to see if a special type of PET scan could help doctors better manage a serious fungal infection called hepatosplenic candidiasis. The infection mainly affects the liver and spleen of cancer patients with weakened immune systems. Researchers tested if the scan co…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
Scientists test how cancer drug works in different patients
Knowledge-focused CompletedThis early-stage study aimed to understand how the body processes the cancer drug belinostat in patients with advanced solid tumors or blood cancers that have returned or stopped responding to treatment. Researchers specifically looked at how different genetic backgrounds affect …
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC